Celularity Inc - Class A
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Did you know?
CELU's revenue grew at a 3.9% CAGR over the last 6 years.
Current Price
$0.98
+2.83%Profile
Valuation (TTM)
Market Cap$27.88M
P/E-0.30
EV—
P/B—
Shares Out28.33M
P/Sales1.05
Revenue$26.55M
EV/EBITDA—
Celularity Inc - Class A (CELU) Stock Analysis
Market Cap$27.88M
Current Price$0.98
P/E Ratio-0.30
Forward P/E—
PEG Ratio-0.01
EPS$-3.59
Book Value$-1.34
P/B Ratio—
CELU Financial Charts
FCF vs CAPEX
FCFCAPEX
Cash vs Debt
Net Debt: 25M
Revenue
21M
FY19
14M
FY20
21M
FY21
18M
FY22
23M
FY23
54M
FY24
27M
FY25
Net Income
—
FY19
—
FY20
—
FY21
14M
FY22
—
FY23
—
FY24
—
FY25
CELU 52-Week Range
$0.93
$4.15
50-Day MA: $1.22200-Day MA: $1.87
Did you know?
CELU's revenue grew at a 3.9% CAGR over the last 6 years.
Celularity Inc - Class A (CELU) Financial Summary
Celularity Inc - Class A (CELU) is a Healthcare company in the Biotechnology industry, listed on NASDAQ. The stock currently trades at $0.98 with a market capitalization of $27.88M.
Key valuation metrics include a P/E ratio of -0.30, and EPS of $-3.59. The company reports a profit margin of -345.4%.
CELU Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $27.88M |
| P/E Ratio | -0.30 |
| EPS | $-3.59 |
| P/S Ratio | 1.05 |
| Profit Margin | -345.4% |
CELU Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY19 | $21.15M | $-211.88M |
| FY20 | $14.28M | $-208.23M |
| FY21 | $21.34M | $-100.12M |
| FY22 | $17.98M | $14.19M |
| FY23 | $22.77M | $-196.29M |
| FY24 | $54.22M | $-57.89M |
| FY25 | $26.55M | $-91.72M |
CELU Quality Indicators
Celularity Inc - Class A maintains a profit margin of -345.4% and an operating margin of -230.9%. The current ratio is 0.15.
CELU Free Cash Flow
Celularity Inc - Class A generated $-13.25M in trailing twelve-month free cash flow, representing an FCF yield of -47.54%. This low FCF yield may reflect heavy reinvestment or growth spending.
CELU Shares Outstanding
Celularity Inc - Class A has 0.03 billion shares outstanding at a share price of $0.98, giving it a market capitalization of $27.88M.